Developmental aspects of human hepatic drug glucuronidation in young children and adults

Gut

Volumn 50, Issue 2, 2002, Pages 259-265

  Strassburg, C P ^a   Strassburg, A ^a   Kneip, S ^a   Barut, A ^a   Tukey, R H ^b   Rodeck, B ^a   Manns, M P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 TERT BUTYLPHENOL; AMITRIPTYLINE; BUPRENORPHINE; ESTRONE; GLUCURONIDE; GLUCURONOSYLTRANSFERASE; IBUPROFEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG GLUCURONIDATION; ENZYME ACTIVITY; ENZYME ASSAY; FETUS; FETUS DEVELOPMENT; GENE CONTROL; GENE EXPRESSION REGULATION; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; INFANT; LIVER DEVELOPMENT; LIVER METABOLISM; PERINATAL DEVELOPMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CHILD, PRESCHOOL; GENE EXPRESSION REGULATION; GLUCURONOSYLTRANSFERASE; HUMANS; INFANT; LIVER; MICROSOMES, LIVER; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 0036150897     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.50.2.259     Document Type: Article

References (46)

1. Human UDP-glucuronosyltransferases: Metabolism, expression, and disease
2. The UDP glucuronosyltransferase gene superfamily: Suggested nomenclature based on evolutionary divergence
3. Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer
4. Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: Identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue
5. Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8
6. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues
7. Chromosomal localization, structure, and regulation of the UGT2B17 gene, encoding a C19 steroid metabolizing enzyme
8. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus
9. UDP-glucuronosyltransferase activity in human liver and colon
10. Polymorphic gene expression and interindividual variation af UDP-glucuronosyltransferase activity in human small intestine
11. Studies of UDP-glucuronyltransferase activities in human liver microsomes
12. Function and regulation of UDP-glucuronosyltransferase genes in health and liver disease: Report of the Seventh International Workshop on Glucuronidation, September 1993, Pitlochry, Scotland
13. Isolation and characterization of hyodeoxycholic-acid: UDP-glucuronosyltransferase from human liver
14. Formation of bile acid glucosides by a sugar nucleotide-independent glucosyltransferase isolated from human liver microsomes
15. Sulphation and glucuronidation of ethinyloestradiol in human liver in vitro
16. Characterization and tissue specificity of a monoclonal antibody against human uridine 5′-diphosphate-glucuronosyltransferase
17. Development of human liver UDP-glucuronosyltransferases
18. The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver
19. Development of multiple activities of UDP-glucuronyltransferase in human liver
20. Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver
21. Development of the glucuronyltransferase and sulphotransferase towards 2-naphthol in human fetus
22. The inadequacy of perinatal glucuronidation: Immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes
23. Glucuronidation in humans. Pharmacogenetic and developmental aspects
24. Antibiotic therapy for severe infections in infants and children
25. Autoimmunity in liver diseases
26. Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis
27. Human UGT2B7 catalyzes morphine glucuronidation
28. Hepatic and extrahepatic glucuronidation of bile acids in man. Characterization of bile acid uridine 5′-diphosphate- glucuronosyltransferase in hepatic, renal, and intestinal microsomes
29. Bile acid UDP-glucoronyltransferase from human liver. Properties and studies on aglycone substrate specificity
30. Tissue distribution of drug-metabolizing enzymes in humans
31. Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3
32. Identification of cyclosporine A and tacrolimus glucuronidation in human liver and the gastrointestinal tract by a differentially expressed UDP-glucuronosyltransferase: UGT2B7
33. Characterization of UDP-glucuronosyltransferases active on steroid hormones
34. Inhibition of human and rabbit liver steroid and xenobiotic UDP-glucuronosyltransferases by tertiary amine drugs-implications for adverse drug reactions
35. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium
36. Cloning and stable expression of a new member of the human liver phenol/bilirubin: UDP-glucuronosyltransferase cDNA family
37. Drug and xenobiotic glucuronidation catalysed by cloned human liver UDP-glucuronosyltransferases stably expressed in tissue culture cell lines
38. Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family
39. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human microsomal UDP-glucuronosyltransferases: Identification of specific UGT1 A family isoforms involved
40. Phospholipid-dependence of oestrone UDP-glucuronyltransferase and p-nitrophenol UDP-glucuronyltransferase
41. Acyl-CoA binding and acylation of UDP-glucuronosyltransferase isoforms of rat liver: Their effect on enzyme activity
42. Inhibition of UDP-glucuronosyltransferase activity by fatty acyl-CoA. Kinetic studies and structure-activity relationship
43. Glucuronidation of drugs by hepatic microsomes derived from healthy and cirrhotic human livers
44. Localization of uridine 5′-diphosphate-glucuronosyltransferase in human liver injury
45. UDP glucuronosyltransferase in the cirrhotic rat liver